ImmunoBiology Ltd.
https://immbio.net/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From ImmunoBiology Ltd.
Third Rock rolls $47m dice on cancer immunotherapy and Jounce 'dream team'
As one of the founders and the sole funder for Jounce Therapeutics' $47 million Series A venture funding round, Third Rock Ventures has placed a big bet on cancer immunotherapies, but the firm is working with a group of clinicians and researchers hand-picked to ensure that at least some of Jounce's wagers pay off.
Latest $110m incubator would add to recent early research investment in San Diego
The latest in a string of investments to boost biotechnology innovation in San Diego is a $110 million proposal to build a "Center for Innovative Therapeutics" on the University of California's local campus.
Recent Financings of Private Companies (03/2006)
Each month, Start-Up presents a comprehensive review of young, private life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation & reagent sectors.
Company Information
- Industry
- Biotechnology
-
Pharmaceuticals
- Vaccines
- Other Names / Subsidiaries
-
- ImmBio
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice